1. Home
  2. ICUI vs NVST Comparison

ICUI vs NVST Comparison

Compare ICUI & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • NVST
  • Stock Information
  • Founded
  • ICUI 1984
  • NVST 2018
  • Country
  • ICUI United States
  • NVST United States
  • Employees
  • ICUI N/A
  • NVST N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • NVST Medical/Dental Instruments
  • Sector
  • ICUI Health Care
  • NVST Health Care
  • Exchange
  • ICUI Nasdaq
  • NVST Nasdaq
  • Market Cap
  • ICUI 3.5B
  • NVST 3.3B
  • IPO Year
  • ICUI 1992
  • NVST 2019
  • Fundamental
  • Price
  • ICUI $142.87
  • NVST $17.77
  • Analyst Decision
  • ICUI Buy
  • NVST Hold
  • Analyst Count
  • ICUI 5
  • NVST 12
  • Target Price
  • ICUI $197.50
  • NVST $20.45
  • AVG Volume (30 Days)
  • ICUI 269.6K
  • NVST 2.7M
  • Earning Date
  • ICUI 05-08-2025
  • NVST 05-01-2025
  • Dividend Yield
  • ICUI N/A
  • NVST N/A
  • EPS Growth
  • ICUI N/A
  • NVST N/A
  • EPS
  • ICUI N/A
  • NVST N/A
  • Revenue
  • ICUI $2,382,046,000.00
  • NVST $2,503,900,000.00
  • Revenue This Year
  • ICUI $0.84
  • NVST $2.29
  • Revenue Next Year
  • ICUI $2.91
  • NVST $3.15
  • P/E Ratio
  • ICUI N/A
  • NVST N/A
  • Revenue Growth
  • ICUI 5.44
  • NVST N/A
  • 52 Week Low
  • ICUI $95.44
  • NVST $14.22
  • 52 Week High
  • ICUI $196.26
  • NVST $23.00
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 54.65
  • NVST 62.38
  • Support Level
  • ICUI $131.73
  • NVST $16.29
  • Resistance Level
  • ICUI $142.00
  • NVST $17.59
  • Average True Range (ATR)
  • ICUI 5.87
  • NVST 0.67
  • MACD
  • ICUI 0.68
  • NVST 0.28
  • Stochastic Oscillator
  • ICUI 89.16
  • NVST 91.04

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Share on Social Networks: